Euclidean Capital LLC Alector, Inc. Transaction History
Euclidean Capital LLC
- $735 Million
- Q4 2024
A detailed history of Euclidean Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 1,307,858 shares of ALEC stock, worth $2.45 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
1,307,858
Previous 1,307,858
-0.0%
Holding current value
$2.45 Million
Previous $6.11 Million
59.54%
% of portfolio
0.34%
Previous 0.67%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
155Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$18.1 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$10.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$3.58 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$3.46 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $154M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...